Anti-RSV Neutralizing Antibody (V3S-0522-YC7554) (CAT#: V3S-0522-YC7554)

Send Inquiry
  • fig1
    Figure 1 Anti-RSV Monoclonal Antibody (V3S-0522-YC7554) in WB
  • fig1
    Figure 2 Anti-RSV Monoclonal Antibody (V3S-0522-YC7554) in DB

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Respiratory syncytial virus. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Respiratory syncytial virus (RSV)
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application DB; WB; ELISA; Neut; FuncS
Application Notes The antibody is recommended for detection of RSV by WB, ELISA, Neut, FuncS assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target RSV
Alternative Name Human respiratory syncytial virus; RSV
Research Area Microbiology; Infectious Disease

Tested Data

WB

Figure 1 Anti-RSV Monoclonal Antibody (V3S-0522-YC7554) in WB

Western blot analysis of V3S-0522-YC7554 was performed by loading Human respiratory syncytial virus (RSV) (A2) Fusion glycoprotein / RSV-F Protein (His Tag) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0522-YC7554 and HRP Goat Anti-Human IgG as a secondary antibody. Chemiluminescent detection was performed.
Lane 1: Reduced antigen (1 μg)

Figure 1 Anti-RSV Monoclonal Antibody (V3S-0522-YC7554) in WB

DB

Figure 2 Anti-RSV Monoclonal Antibody (V3S-0522-YC7554) in DB

Dot Blot analysis of V3S-0522-YC7554 was performed by coating with Human respiratory syncytial virus (RSV) (A2) Fusion glycoprotein / RSV-F Protein (His Tag).

V3S-0522-YC7554 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-Human IgG as a secondary antibody (1: 2000)

Figure 2 Anti-RSV Monoclonal Antibody (V3S-0522-YC7554) in DB

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry